Atlas Trials

Kidney Transplant Recipients

36 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Kidney Transplant Recipients

RecordFirmDate
The Effects of Physical Activity Behavior Change in Kidney Transplant Recipients (NCT05425498)Dokuz Eylul University2022-06-30
An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients (NCT05293704)Lee's Pharmaceutical Limited2022-05-01
COVID Protection After Transplant-Immunosuppression Reduction (NCT05077254)National Institute of Allergy and Infectious Diseases (NIAID)2021-12-06
COVID-19 Protection After Transplant Pilot Study (NCT04969263)National Institute of Allergy and Infectious Diseases (NIAID)2021-08-10
Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients (NCT04965935)University Health Network, Toronto2021-07-15
Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients (NCT04757883)University Hospital, Strasbourg, France2021-02-02
Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen (NCT04444843)First Affiliated Hospital Xi'an Jiaotong University2021-01-22
Prostate Cancer in Renal Transplants Recipients (NCT04642833)University of Florence2020-11-18
Treg Modulation With CD28 and IL-6 Receptor Antagonists (NCT04066114)National Institute of Allergy and Infectious Diseases (NIAID)2019-12-11
Envarsus XR Compared to Immediate Release Tacrolimus (NCT03979365)Mayo Clinic2019-07-18
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation (NCT02424227)CareDx2015-04-01
Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients (NCT02392312)Astellas Pharma China, Inc.2015-01-21
Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study (NCT02555566)University Hospital, Rouen2014-03-01
Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring (NCT02058875)University of Saskatchewan2014-02-01
Pharmacokinetic Studies of Tacrolimus in Transplant Patients (NCT01889758)University of Cincinnati2013-06-01
KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) (NCT02042963)Seoul National University Hospital2012-03-01
A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus (NCT01608412)Hospital de Clinicas de Porto Alegre2012-02-01
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation (NCT01517984)National Institute of Allergy and Infectious Diseases (NIAID)2010-11-01
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients (NCT01150487)Mayo Clinic2010-10-05
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients (NCT01336296)University of Cincinnati2010-09-01
Measuring and Improving Medication Adherence in Kidney Transplant Patients (NCT02639949)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2010-01-01
Study of the Renal Perfusion in Healthy Volunteers and Renal Transplant Recipients During an Orthostatic Stress (NCT02179411)University Hospital, Angers2009-04-01
A Multivitamin Comparison Study in Kidney Transplant Recipients. (NCT00217100)Mayo Clinic2004-10-01
An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients (NCT00239044)Novartis Pharmaceuticals2002-12-01
Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients (NCT00199667)University Hospital, Limoges2002-10-01
Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients (NCT00005009)National Institute of Allergy and Infectious Diseases (NIAID)1998-02-01

Track Kidney Transplant Recipients automatically

Every clearance here is in the API, with alerts when new ones post.